Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis.

Sinha A, Lieu TA, Paoletti LC, Weinstein MC, Platt R.

Vaccine. 2005 May 2;23(24):3187-95.

PMID:
15837219
2.

Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.

Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC.

Pediatr Infect Dis J. 2008 Dec;27(12):1057-64. doi: 10.1097/INF.0b013e318180b3b9.

PMID:
18989238
3.

Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy.

Velaphi S, Siegel JD, Wendel GD Jr, Cushion N, Eid WM, Sánchez PJ.

Pediatrics. 2003 Mar;111(3):541-7.

PMID:
12612234
4.

Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study.

Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, Patel D, Peters MT, Stoll B, Levine OS.

Pediatrics. 2000 Jan;105(1 Pt 1):21-6.

PMID:
10617699
5.

Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.

Kim SY, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A.

Vaccine. 2014 Apr 7;32(17):1954-63. doi: 10.1016/j.vaccine.2014.01.062. Epub 2014 Feb 11.

PMID:
24530145
6.

Preventing early-onset group B streptococcal sepsis: strategy development using decision analysis.

Benitz WE, Gould JB, Druzin ML.

Pediatrics. 1999 Jun;103(6):e76.

PMID:
10353973
7.

Early-onset group B streptococcal disease in the era of maternal screening.

Puopolo KM, Madoff LC, Eichenwald EC.

Pediatrics. 2005 May;115(5):1240-6.

PMID:
15867030
8.

Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.

Renner RM, Renner A, Schmid S, Hoesli I, Nars P, Holzgreve W, Surbek DV.

J Perinat Med. 2006;34(1):32-8.

PMID:
16489884
9.
10.

Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction.

Haberland CA, Benitz WE, Sanders GD, Pietzsch JB, Yamada S, Nguyen L, Garber AM.

Pediatrics. 2002 Sep;110(3):471-80.

PMID:
12205247
11.

Control of neonatal group B streptococcal infection.

Steele RW.

J R Soc Med. 1993 Dec;86(12):712-5.

12.

Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation.

Davies HD, Raj S, Adair C, Robinson J, McGeer A; Alberta GBS Study Group.

Pediatr Infect Dis J. 2001 Sep;20(9):879-84.

PMID:
11734768
13.
14.

Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.

Akker-van Marle ME, Rijnders ME, Dommelen P, Fekkes M, Wouwe JP, Amelink-Verburg MP, Verkerk PH.

BJOG. 2005 Jun;112(6):820-6.

15.

Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable?

Gilbert GL.

Expert Rev Vaccines. 2004 Aug;3(4):371-4. Review.

PMID:
15270637
16.

Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis.

Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA Jr.

Obstet Gynecol. 1994 Apr;83(4):483-94. Review.

PMID:
8134056
18.

Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis.

Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV.

JAMA. 1993 Sep 22-29;270(12):1442-8.

PMID:
8371444
19.

Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.

Konrad G, Katz A.

Can Fam Physician. 2007 Jun;53(6):1055, 2001:e.1-6, 1054.

20.

Group B streptococcal epidemiology and vaccine needs in developed countries.

Melin P, Efstratiou A.

Vaccine. 2013 Aug 28;31 Suppl 4:D31-42. doi: 10.1016/j.vaccine.2013.05.012. Review.

PMID:
23973345

Supplemental Content

Support Center